Cargando…

A 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging

Diffuse alveolar hemorrhage (DAH) is a rare, but potentially fatal, complication of antiphospholipid syndrome, and may present with acute and fulminant symptoms. We report a case of DAH presenting as sudden onset dyspnea in a gentleman with known antiphospholipid syndrome. Chest computed tomography...

Descripción completa

Detalles Bibliográficos
Autores principales: Helgeson, Scott A, Heckman, Alexander J, McCain, Josiah D, Cowart, Jennifer B, Maniaci, Michael J, Garland, Jeffrey L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169198/
https://www.ncbi.nlm.nih.gov/pubmed/30302263
http://dx.doi.org/10.1093/omcr/omy072
_version_ 1783360474438434816
author Helgeson, Scott A
Heckman, Alexander J
McCain, Josiah D
Cowart, Jennifer B
Maniaci, Michael J
Garland, Jeffrey L
author_facet Helgeson, Scott A
Heckman, Alexander J
McCain, Josiah D
Cowart, Jennifer B
Maniaci, Michael J
Garland, Jeffrey L
author_sort Helgeson, Scott A
collection PubMed
description Diffuse alveolar hemorrhage (DAH) is a rare, but potentially fatal, complication of antiphospholipid syndrome, and may present with acute and fulminant symptoms. We report a case of DAH presenting as sudden onset dyspnea in a gentleman with known antiphospholipid syndrome. Chest computed tomography angiography with pulmonary embolism protocol showed right lower lobe segmental filling defects, upper-lobe predominant diffuse ground-glass opacities, and centrilobular nodules bilaterally. The presence of DAH can be confirmed by bronchoalveolar lavage with serial aliquots, but this procedure typically does not elucidate the specific etiology for the hemorrhage. The treatment for patients with severe disease typically consists of a combination of immunosuppressive medications in the form of high-dose intravenous glucocorticoids plus rituximab, cyclophosphamide or mycophenolate; and/or plasma exchange. This case both provides an example of high-quality diagnostic imaging of diffuse alveolar hemorrhage as well as demonstrates the clinical and image-based improvement after treatment.
format Online
Article
Text
id pubmed-6169198
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-61691982018-10-09 A 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging Helgeson, Scott A Heckman, Alexander J McCain, Josiah D Cowart, Jennifer B Maniaci, Michael J Garland, Jeffrey L Oxf Med Case Reports Case Report Diffuse alveolar hemorrhage (DAH) is a rare, but potentially fatal, complication of antiphospholipid syndrome, and may present with acute and fulminant symptoms. We report a case of DAH presenting as sudden onset dyspnea in a gentleman with known antiphospholipid syndrome. Chest computed tomography angiography with pulmonary embolism protocol showed right lower lobe segmental filling defects, upper-lobe predominant diffuse ground-glass opacities, and centrilobular nodules bilaterally. The presence of DAH can be confirmed by bronchoalveolar lavage with serial aliquots, but this procedure typically does not elucidate the specific etiology for the hemorrhage. The treatment for patients with severe disease typically consists of a combination of immunosuppressive medications in the form of high-dose intravenous glucocorticoids plus rituximab, cyclophosphamide or mycophenolate; and/or plasma exchange. This case both provides an example of high-quality diagnostic imaging of diffuse alveolar hemorrhage as well as demonstrates the clinical and image-based improvement after treatment. Oxford University Press 2018-10-03 /pmc/articles/PMC6169198/ /pubmed/30302263 http://dx.doi.org/10.1093/omcr/omy072 Text en © The Author(s) 2018. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Case Report
Helgeson, Scott A
Heckman, Alexander J
McCain, Josiah D
Cowart, Jennifer B
Maniaci, Michael J
Garland, Jeffrey L
A 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging
title A 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging
title_full A 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging
title_fullStr A 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging
title_full_unstemmed A 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging
title_short A 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging
title_sort 32-year-old man with hypoxemia and bilateral upper-lobe predominant ground-glass infiltrates on chest imaging
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169198/
https://www.ncbi.nlm.nih.gov/pubmed/30302263
http://dx.doi.org/10.1093/omcr/omy072
work_keys_str_mv AT helgesonscotta a32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging
AT heckmanalexanderj a32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging
AT mccainjosiahd a32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging
AT cowartjenniferb a32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging
AT maniacimichaelj a32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging
AT garlandjeffreyl a32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging
AT helgesonscotta 32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging
AT heckmanalexanderj 32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging
AT mccainjosiahd 32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging
AT cowartjenniferb 32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging
AT maniacimichaelj 32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging
AT garlandjeffreyl 32yearoldmanwithhypoxemiaandbilateralupperlobepredominantgroundglassinfiltratesonchestimaging